Amerant Bancorp Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amerant Bancorp in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Amerant Bancorp stock.
View analyst ratings for Amerant Bancorp or view top-rated stocks.

Wall Street analysts have given Amerant Bancorp a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Amerant Bancorp wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Amerant Bancorp saw a increase in short interest in August. As of August 13th, there was short interest totaling 295,000 shares, an increase of 26.9% from the July 29th total of 232,500 shares. Based on an average daily volume of 77,900 shares, the days-to-cover ratio is currently 3.8 days. Currently, 1.4% of the company's shares are sold short.
View Amerant Bancorp's Short Interest.

Amerant Bancorp is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Amerant Bancorp.

Amerant Bancorp Inc. (NASDAQ:AMTB) announced its earnings results on Wednesday, July, 21st. The company reported $0.51 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.12. The business earned $65.71 million during the quarter, compared to the consensus estimate of $62.18 million. Amerant Bancorp had a trailing twelve-month return on equity of 6.03% and a net margin of 13.17%.
View Amerant Bancorp's earnings history.

Amerant Bancorp's stock was trading at $14.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AMTB stock has increased by 69.5% and is now trading at $24.58.
View which stocks have been most impacted by COVID-19.

7 analysts have issued 1 year price targets for Amerant Bancorp's shares. Their forecasts range from $23.50 to $30.00. On average, they anticipate Amerant Bancorp's stock price to reach $25.43 in the next twelve months. This suggests a possible upside of 3.5% from the stock's current price.
View analysts' price targets for Amerant Bancorp or view top-rated stocks among Wall Street analysts.

35 employees have rated Amerant Bancorp CEO Millar Wilson on Glassdoor.com. Millar Wilson has an approval rating of 70% among Amerant Bancorp's employees.

Some companies that are related to Amerant Bancorp include First National of Nebraska (FINN), Akbank T.A.S. (AKBTY), Community Bank System (CBU), F.N.B. (FNB), Simmons First National (SFNC), Old National Bancorp (ONB), Cadence Bancorporation (CADE), Fulton Financial (FULT), Washington Federal (WAFD), First Financial Bancorp. (FFBC), First Merchants (FRME), WSFS Financial (WSFS), WesBanco (WSBC), First Midwest Bancorp (FMBI) and Sandy Spring Bancorp (SASR).
View all of AMTB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amerant Bancorp investors own include (TOT), Wells Fargo & Company (WFC), Weyerhaeuser (WY), BioMarin Pharmaceutical (BMRN), CBTX (CBTX), General Mills (GIS), GlaxoSmithKline (GSK), International Paper (IP), Nordstrom (JWN) and Kirkland Lake Gold (KL).

(AMTB) raised $82 million in an IPO on the week of December 17th 2018. The company issued 6,300,000 shares at $13.00 per share. Raymond James, Keefe, Bruyette & Woods (A Stifel Company) and Stephens served as the underwriters for the IPO and SunTrust Robinson Humphrey and FIG Partners were co-managers.

Amerant Bancorp trades on the NASDAQ under the ticker symbol "AMTB."

Amerant Bancorp's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (4.23%), Vanguard Group Inc. (2.84%), State Street Corp (1.16%), Geode Capital Management LLC (0.97%), Millennium Management LLC (0.61%) and Northern Trust Corp (0.55%). Company insiders that own Amerant Bancorp stock include Gerald P Plush and Miguel Palacios.
View institutional ownership trends for Amerant Bancorp.

AMTB stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Millennium Management LLC, Northern Trust Corp, Bank of New York Mellon Corp, Bank of America Corp DE, Geode Capital Management LLC, Citadel Advisors LLC, and BNP Paribas Arbitrage SA.
View insider buying and selling activity for Amerant Bancorp or view top insider-selling stocks.

AMTB stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Monarch Partners Asset Management LLC, Marshall Wace LLP, Marshall Wace LLP, Nuveen Asset Management LLC, State Street Corp, Vanguard Group Inc., and Zacks Investment Management. Company insiders that have bought Amerant Bancorp stock in the last two years include Gerald P Plush, and Miguel Palacios.
View insider buying and selling activity for Amerant Bancorp or or view top insider-buying stocks.

Shares of AMTB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMTB stock can currently be purchased for approximately $24.58.

Amerant Bancorp has a market capitalization of $921.28 million and generates $334.02 million in revenue each year. The company earns $-1,720,000.00 in net income (profit) each year or $0.09 on an earnings per share basis.

Amerant Bancorp employs 714 workers across the globe.

The official website for Amerant Bancorp is www.amerantbank.com.

Amerant Bancorp is headquartered at 220 ALHAMBRA CIRCLE, CORAL GABLES FL, 33134.

Amerant Bancorp's mailing address is 220 ALHAMBRA CIRCLE, CORAL GABLES FL, 33134. The company can be reached via phone at (305) 460-8728 or via email at [email protected]